Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Therapeuticsmd Inc
(NQ:
TXMD
)
1.770
UNCHANGED
Streaming Delayed Price
Updated: 3:27 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Therapeuticsmd Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying
Today 7:36 EDT
Via
Benzinga
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q2 2024
August 12, 2024
TherapeuticsMD just reported results for the second quarter of 2024.
Via
InvestorPlace
TherapeuticsMD Announces Second Quarter 2024 Financial Results
August 12, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023
June 28, 2024
TherapeuticsMD just reported results for the fourth quarter of 2023.
Via
InvestorPlace
TXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024
May 10, 2024
TherapeuticsMD just reported results for the first quarter of 2024.
Via
InvestorPlace
TherapeuticsMD Announces First Quarter 2024 Financial Results
May 10, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
June 05, 2023
Via
Benzinga
TherapeuticsMD Announces Full Year 2023 Financial Results
March 29, 2024
From
TherapeuticsMD, Inc.
Via
Business Wire
5 Value Stocks In The Healthcare Sector
March 04, 2024
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 12, 2024
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
December 25, 2023
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
November 27, 2023
Via
Benzinga
TherapeuticsMD Announces Third Quarter 2023 Financial Results
November 14, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
Nasdaq Jumps 100 Points; US Trade Deficit Widens In September
November 07, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
During the session on Thursday, 461 stocks hit new 52-week lows.
Via
Benzinga
TherapeuticsMD Announces Second Quarter 2023 Financial Results
August 14, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces First Quarter 2023 Financial Results
May 15, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model Transition
April 07, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 23, 2023
We're starting off the week with a breakdown of the biggest pre-market stock movers traders will want to watch for Monday!
Via
InvestorPlace
TherapeuticsMD Completes Transaction to License Its Products to Mayne Pharma
January 03, 2023
From
TherapeuticsMD, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
January 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 05, 2022
Via
Benzinga
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
December 04, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Third Quarter 2022 Financial Results
November 14, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces Additional $7 Million Private Placement
October 31, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
TherapeuticsMD Announces $7 Million Private Placement
October 03, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 27, 2022
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
Via
Benzinga
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
September 12, 2022
From
TherapeuticsMD, Inc.
Via
Business Wire
Looking Into TherapeuticsMD's Return On Capital Employed
September 09, 2022
According to Benzinga Pro, during Q2, TherapeuticsMD (NASDAQ:TXMD) earned $112.28 million, a 329.05% increase from the preceding quarter. TherapeuticsMD also posted a total of $28.56 million in sales,...
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.